These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 17933418)

  • 41. Modification of cardiovascular ion channels by gene therapy.
    Telemaque S; Marsh JD
    Expert Rev Cardiovasc Ther; 2009 Aug; 7(8):939-53. PubMed ID: 19673672
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recent advances in the use of protein transduction domains for the delivery of peptides, proteins and nucleic acids in vivo.
    Snyder EL; Dowdy SF
    Expert Opin Drug Deliv; 2005 Jan; 2(1):43-51. PubMed ID: 16296734
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recent development of nonviral gene delivery systems with virus-like structures and mechanisms.
    Itaka K; Kataoka K
    Eur J Pharm Biopharm; 2009 Mar; 71(3):475-83. PubMed ID: 18955136
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gene therapy in wound healing: present status and future directions.
    Branski LK; Pereira CT; Herndon DN; Jeschke MG
    Gene Ther; 2007 Jan; 14(1):1-10. PubMed ID: 16929353
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Liposomes in ultrasonic drug and gene delivery.
    Huang SL
    Adv Drug Deliv Rev; 2008 Jun; 60(10):1167-76. PubMed ID: 18479776
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Recent developments in adeno-associated virus vector technology.
    Büning H; Perabo L; Coutelle O; Quadt-Humme S; Hallek M
    J Gene Med; 2008 Jul; 10(7):717-33. PubMed ID: 18452237
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interactions of adenovirus vectors with blood: implications for intravascular gene therapy applications.
    Parker AL; Nicklin SA; Baker AH
    Curr Opin Mol Ther; 2008 Oct; 10(5):439-48. PubMed ID: 18830919
    [TBL] [Abstract][Full Text] [Related]  

  • 48. How not to be seen: immune-evasion strategies in gene therapy.
    Zaldumbide A; Hoeben RC
    Gene Ther; 2008 Feb; 15(4):239-46. PubMed ID: 18046427
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Creation of polymeric micelles as devise for drug delivery inspired by structural properties of natural viruses].
    Harada A; Kataoka K
    Tanpakushitsu Kakusan Koso; 2000 May; 45(7):1265-72. PubMed ID: 10806867
    [No Abstract]   [Full Text] [Related]  

  • 50. Targeting cancer by transcriptional control in cancer gene therapy and viral oncolysis.
    Dorer DE; Nettelbeck DM
    Adv Drug Deliv Rev; 2009 Jul; 61(7-8):554-71. PubMed ID: 19394376
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Toward development of artificial viruses for gene therapy: a comparative evaluation of viral and non-viral transfection.
    Douglas KL
    Biotechnol Prog; 2008; 24(4):871-83. PubMed ID: 18335953
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Photochemical drug and gene delivery.
    Berg K; Selbo PK; Prasmickaite L; Høgset A
    Curr Opin Mol Ther; 2004 Jun; 6(3):279-87. PubMed ID: 15264430
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Virus engineering: functionalization and stabilization.
    Mateu MG
    Protein Eng Des Sel; 2011 Jan; 24(1-2):53-63. PubMed ID: 20923881
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High-throughput screening of enzyme libraries: in vitro evolution of a beta-galactosidase by fluorescence-activated sorting of double emulsions.
    Mastrobattista E; Taly V; Chanudet E; Treacy P; Kelly BT; Griffiths AD
    Chem Biol; 2005 Dec; 12(12):1291-300. PubMed ID: 16356846
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nucleic acid drug delivery and targeting.
    Takakura Y
    Pharm Res; 2011 Apr; 28(4):691-3. PubMed ID: 21347564
    [No Abstract]   [Full Text] [Related]  

  • 56. Hybrid of baculovirus and galactosylated PEI for efficient gene carrier.
    Kim YK; Choi JY; Jiang HL; Arote R; Jere D; Cho MH; Je YH; Cho CS
    Virology; 2009 Apr; 387(1):89-97. PubMed ID: 19272627
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Advances in laboratory evolution of enzymes.
    Bershtein S; Tawfik DS
    Curr Opin Chem Biol; 2008 Apr; 12(2):151-8. PubMed ID: 18284924
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Easy approach to DNA shuffling: its potential implication in health sciences.
    Pokhrel S; Lamsal M; Wang ZX
    Nepal Med Coll J; 2006 Jun; 8(2):136-9. PubMed ID: 17017407
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multivalent antibodies: when design surpasses evolution.
    Cuesta AM; Sainz-Pastor N; Bonet J; Oliva B; Alvarez-Vallina L
    Trends Biotechnol; 2010 Jul; 28(7):355-62. PubMed ID: 20447706
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Recent development of nucleic acid drug].
    Murakami A; Yamaoka T; Iwase R
    Nihon Rinsho; 1998 Mar; 56(3):563-72. PubMed ID: 9549337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.